<!doctype html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width,initial-scale=1"><meta name="x-apple-disable-message-reformatting"><!--[if !mso]><!--><meta http-equiv="X-UA-Compatible" content="IE=edge"><!--<![endif]--><title></title><!--[if mso]> <style type="text/css"> table { border-collapse: collapse; border: 0; border-spacing: 0; margin: 0; } div, td { padding: 0; } div { margin: 0 !important; } ul, li { margin: 0; } </style> <noscript> <xml> <o:OfficeDocumentSettings> <o:AllowPNG/> <o:PixelsPerInch>96</o:PixelsPerInch> </o:OfficeDocumentSettings> </xml> </noscript> <![endif]--><style>@media screen and (max-width: 460px) { .stb-two-col .stb-column { max-width: 100% !important; } } @media screen and (min-width: 461px) { .stb-two-col .stb-column { max-width: 50% !important; } } @media screen and (max-width: 640px) { img.stb-justify { width: 100% !important; } } .stb-one-col p, .stb-two-col p { margin: 0px !important; }</style></head><body class="$stb-htmlv3$"><div role="article" aria-roledescription="email" style="-webkit-text-size-adjust: 100%;-ms-text-size-adjust: 100%;padding: 20px 0px;margin: 0 auto;"><div style="height:0px;max-height:0px;border-width:0px;border: 0px;border-color:initial;border-image:initial;visibility:hidden;line-height:0px;font-size:0px;overflow:hidden;display:none;"></div><table id="$beacon$"><tbody><tr><td></td></tr></tbody></table><table id="stb-container" role="presentation" style="width:100%;" border="0" bordercolor=""><tbody><tr><td align="center"><!--[if mso]> <table role="presentation" align="center" style="width:630px;background:#ffffff;"> <tr> <td> <div class="outer"> <![endif]--><!--[if !mso]><!--><div class="outer" style="width:100%;max-width:630px;background:#ffffff;margin: 0px auto;"><!--<![endif]--><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td class="stb-text-box" style="padding:0 0;text-align:left;margin:0px;line-height:1.7;word-break:break-word;font-size:12px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#747579;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%" class="stb-permalink"><tbody><tr><td style="padding:15px 15px 0px 15px;"><div><span style="font-weight: bold; font-style: italic;" class="stb-bold stb-italic">2025-08-01</span></div></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:0px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="text-align:center;font-size:0;box-sizing:border-box;"><a href="https://www.brpinsight.com/brand/11290" target="_blank" style="text-decoration: none; color: #0000ff;"><img src="https://img2.stibee.com/440332_2907895_1753165422184361025.png" alt="" style="width:476px;display:inline;vertical-align:bottom;text-align:center;max-width:100% !important;height:auto;border:0;" width="476" class="stb-center"></a></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:0px 15px 0px 15px;"><div style="text-align: center;"><h2 class="main-visual--title" style="padding: 0px; margin: 0px; line-height: 1.7;"><span style="font-size: 16px;">제약 산업의 주요 뉴스를 고르고, </span><span style="font-size: 16px;">데이터를 더해 매일 뉴스레터를 발행합니다. </span></h2></div></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;background:#000000;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:5px 15px 5px 15px;"><div><a href="https://www.dailypharm.com/Users/News/NewsView.html?ID=325481" target="_blank" style="text-decoration: none; color: #0000ff;"><span style="font-weight: bold; color: #f6f3fa;" class="stb-bold stb-fore-colored">불순물 초과 검출 가능 인데놀정 회수 위기? 🔗</span></a></div></td></tr></tbody></table><!--[if !mso]><!--><div class="stb-two-col" style="border:0;font-size:0;" name="base2column"><!--<![endif]--><!--[if mso]> <div class='stb-two-col' style='text-align:center;' > <![endif]--><!--[if mso]> <table role='presentation' width='100%' cellpadding='0' cellspacing='0' style='border:0;'> <tr> <![endif]--><!--[if mso]> <td style='width:50%;padding:15px 15px 0px 15px;' valign='top'> <![endif]--><div class="stb-column" style="max-width:315px;width:100%!important;margin:0;vertical-align:top;border-collapse:collapse;box-sizing:border-box;font-size:16px;mso-table-lspace:0pt;mso-table-rspace:0pt;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;width:100%;display:inline-block;vertical-align:top;"><!--[if !mso]><!--><div style="padding:15px 15px 0px 15px;"><!--<![endif]--><!--[if mso]> <div > <![endif]--><div style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;"><div><span style="font-size: 14px;">식약처는 최근 잇따른 의약품 내 불순물 검출에 따라 주요 성분에 대한 안전성 점검을 강화하고 있습니다.<span style="font-weight: bold;" class="stb-bold"> </span></span><span style="font-size: 14px;"><span style="font-weight: bold;" class="stb-bold">고혈압 치료제 ‘프로프라놀롤’에서도 니트로사민계 불순물 초과 검출 가능성이 제기돼 회수 조치가 검토 중이며, 현재 사실상 ‘인데놀’ 1개 품목만 유통</span>되고 있습니다. </span><span style="font-size: 14px;">이에 따라 식약처는 수급 공백에 대비해, 의약단체를 대상으로 환자 치료 영향 및 대체약 현황에 대한 의견을 수렴하고 있습니다. </span><span style="font-size: 14px;">[데일리팜 - 25.07.31]</span></div></div></div></div><!--[if mso]> </td> <![endif]--><!--[if mso]> <td style='width:50%;padding:15px 15px 0px 15px;' valign='top'> <![endif]--><div class="stb-column" style="max-width:315px;width:100%!important;margin:0;vertical-align:top;border-collapse:collapse;box-sizing:border-box;font-size:16px;mso-table-lspace:0pt;mso-table-rspace:0pt;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;width:100%;display:inline-block;vertical-align:top;"><!--[if !mso]><!--><div style="padding:15px 15px 0px 15px;"><!--<![endif]--><!--[if mso]> <div > <![endif]--><p style="text-align:center;font-size:0;box-sizing:border-box;"><img src="https://img2.stibee.com/440332_2928016_1754020671997469472.jpg" alt="" style="width:auto;display:inline;vertical-align:bottom;text-align:center;max-width:100% !important;height:auto;border:0;" width="194" class="stb-center"></p></div></div><!--[if mso]> </td> <![endif]--><!--[if mso]> </tr> </table> <![endif]--></div><table role="presentation" class="stb-one-col" style="width: 100%;background:#ffffff;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:15px 15px 15px 15px;border:0;width:100%;text-align:center;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#000000;mso-padding-alt:0px;border-radius:3px;border:1px solid ;mso-line-height-rule:exactly;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:3px;padding:17px 20px;text-align:center;" valign="top"><a href="https://www.brpinsight.com/brand/11051" style="font-size:14px;display:inline-block;color:#000000;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;" target="_blank"><b>BRPInsight 트렌드 - 인데놀정 회수로 영향을 많이 받는 진료과는? [클릭]</b></a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;background:#000000;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:5px 15px 5px 15px;"><h3 style="padding: 0px; margin: 0px; line-height: 1.7;"><span style="font-size: 16px; font-weight: bold; color: #f6f3fa;" class="stb-bold stb-fore-colored"><a href="https://biz.chosun.com/science-chosun/bio/2025/07/31/SE5TIPEXOJAKDCWUFKRB7U33UU/" style="font-weight: bold; color: #f6f3fa; text-decoration: none;" class="stb-bold stb-fore-colored" target="_blank"><strong data-start="87" data-end="125">유한양행 렉라자, 중국까지 진출 🔗</strong></a></span></h3></td></tr></tbody></table><!--[if !mso]><!--><div class="stb-two-col" style="border:0;font-size:0;" name="base2column"><!--<![endif]--><!--[if mso]> <div class='stb-two-col' style='text-align:center;' > <![endif]--><!--[if mso]> <table role='presentation' width='100%' cellpadding='0' cellspacing='0' style='border:0;'> <tr> <![endif]--><!--[if mso]> <td style='width:50%;padding:15px 15px 0px 15px;' valign='top'> <![endif]--><div class="stb-column" style="max-width:315px;width:100%!important;margin:0;vertical-align:top;border-collapse:collapse;box-sizing:border-box;font-size:16px;mso-table-lspace:0pt;mso-table-rspace:0pt;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;width:100%;display:inline-block;vertical-align:top;"><!--[if !mso]><!--><div style="padding:15px 15px 0px 15px;"><!--<![endif]--><!--[if mso]> <div > <![endif]--><div style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;"><p data-pm-slice="0 0 []"><span style="font-size: 14px;">유한양행의 폐암 치료제 ‘렉라자’는 EGFR 변이 비소세포폐암 대상 병용요법으로 미국, 유럽 등 주요국에서 이미 허가를 받은 글로벌 신약입니다. 최근 중국 보건당국(NMPA)에서도 병용요법에 대한 시판 승인을 획득하며 아시아 시장 공략이 본격화에 나섰습니다. </span><span style="font-size: 14px;">유한양행은 이번 승인에 따라 마일스톤 4,500만달러(약 628억원)를 추가로 수령하며, 중국 내 매출 확대와 글로벌 입지 강화가 기대됩니다.</span></p><p data-pm-slice="0 0 []"><span style="font-size: 14px;">[조선비즈 - 25.07.31]</span> </p></div></div></div><!--[if mso]> </td> <![endif]--><!--[if mso]> <td style='width:50%;padding:15px 15px 0px 15px;' valign='top'> <![endif]--><div class="stb-column" style="max-width:315px;width:100%!important;margin:0;vertical-align:top;border-collapse:collapse;box-sizing:border-box;font-size:16px;mso-table-lspace:0pt;mso-table-rspace:0pt;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;width:100%;display:inline-block;vertical-align:top;"><!--[if !mso]><!--><div style="padding:15px 15px 0px 15px;"><!--<![endif]--><!--[if mso]> <div > <![endif]--><p style="text-align:center;font-size:0;box-sizing:border-box;"><img src="https://img2.stibee.com/440332_2928016_1754022004168099084.png" alt="" style="width:216px;display:inline;vertical-align:bottom;text-align:center;max-width:100% !important;height:auto;border:0;" width="216" class="stb-center"></p></div></div><!--[if mso]> </td> <![endif]--><!--[if mso]> </tr> </table> <![endif]--></div><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:5px 15px 5px 15px;border:0;width:100%;text-align:center;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#1b1b1b;mso-padding-alt:0px;border-radius:3px;border:1px solid ;mso-line-height-rule:exactly;width:auto;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:3px;padding:17px 20px;text-align:center;" valign="top"><a href="https://www.brpinsight.com/brand/2892" style="font-size:14px;display:inline-block;color:#1b1b1b;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;width:auto;" target="_blank"><b>BRPInsight 트렌드 - 국내 시장에서 렉라자의 점유율은? [클릭]</b></a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;background:#000000;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:5px 15px 5px 15px;"><h3 class="heading" style="padding: 0px; margin: 0px; line-height: 1.7;"><span style="font-weight: bold; font-size: 16px;" class="stb-bold"><a href="http://www.hitnews.co.kr/news/articleView.html?idxno=67354" style="font-weight: bold; color: #0000ff; text-decoration: none;" class="stb-bold" target="_blank"><span style="color: #f6f3fa;" class="stb-fore-colored"> JW중외제약 2분기 매출 11% 급증 🔗</span></a></span></h3></td></tr></tbody></table><!--[if !mso]><!--><div class="stb-two-col" style="border:0;font-size:0;" name="base2column"><!--<![endif]--><!--[if mso]> <div class='stb-two-col' style='text-align:center;' > <![endif]--><!--[if mso]> <table role='presentation' width='100%' cellpadding='0' cellspacing='0' style='border:0;'> <tr> <![endif]--><!--[if mso]> <td style='width:50%;padding:15px 15px 0px 15px;' valign='top'> <![endif]--><div class="stb-column" style="max-width:315px;width:100%!important;margin:0;vertical-align:top;border-collapse:collapse;box-sizing:border-box;font-size:16px;mso-table-lspace:0pt;mso-table-rspace:0pt;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;width:100%;display:inline-block;vertical-align:top;"><!--[if !mso]><!--><div style="padding:15px 15px 0px 15px;"><!--<![endif]--><!--[if mso]> <div > <![endif]--><div style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;"><p data-pm-slice="0 0 []"><span style="font-size: 14px;">JW중외제약은 ETC 중심 포트폴리오와 고부가가치 제품 확대 전략을 추진해왔습니다. </span><span style="font-size: 14px;">2025년 2분기 매출은 전년 대비 11.2% 증가한 1,897억 원, 영업이익은 103.3% 급증한 254억 원으로 두 자릿수 이익률을 회복했습니다. </span><span style="font-size: 14px;">‘리바로젯’, ‘헴리브라’, ‘페린젝트’ 등 주요 ETC 품목의 성장이 실적 개선을 이끌었습니다. [히트뉴스 - 25.08.01]</span></p></div></div></div><!--[if mso]> </td> <![endif]--><!--[if mso]> <td style='width:50%;padding:15px 15px 0px 15px;' valign='top'> <![endif]--><div class="stb-column" style="max-width:315px;width:100%!important;margin:0;vertical-align:top;border-collapse:collapse;box-sizing:border-box;font-size:16px;mso-table-lspace:0pt;mso-table-rspace:0pt;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;width:100%;display:inline-block;vertical-align:top;"><!--[if !mso]><!--><div style="padding:15px 15px 0px 15px;"><!--<![endif]--><!--[if mso]> <div > <![endif]--><p style="text-align:center;font-size:0;box-sizing:border-box;"><img src="https://img2.stibee.com/440332_2928016_1754024203718109130.png" alt="" style="width:178px;display:inline;vertical-align:bottom;text-align:center;max-width:100% !important;height:auto;border:0;" width="178" class="stb-center"></p></div></div><!--[if mso]> </td> <![endif]--><!--[if mso]> </tr> </table> <![endif]--></div><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:5px 15px 5px 15px;border:0;width:100%;text-align:center;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#1b1b1b;mso-padding-alt:0px;border-radius:3px;border:1px solid ;mso-line-height-rule:exactly;width:auto;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:3px;padding:17px 20px;text-align:center;" valign="top"><a href="https://www.brpinsight.com/brand/3567" style="font-size:14px;display:inline-block;color:#1b1b1b;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;width:auto;" target="_blank"><b>BRPInsight 트렌드 - 피타바+에제티미브 성분은 지금도 성장 중? [클릭]</b></a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;background:#000000;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;padding:5px 15px 5px 15px;"><div><span style="color: #ffffff; font-weight: bold;" class="stb-fore-colored stb-bold"><a href="https://www.medicaltimes.com/Main/News/NewsView.html?ID=1164622" style="font-style: normal; text-decoration: none; color: #ffffff; font-weight: bold;" class="stb-fore-colored stb-bold" target="_blank"><span style="color: #f6f3fa;" class="stb-fore-colored"><span style="font-style: normal; text-decoration: none;">우판권을 획득한 동광레바피드서방정 8월 출시</span> 🔗</span></a></span></div></td></tr></tbody></table><!--[if !mso]><!--><div class="stb-two-col" style="border:0;font-size:0;" name="base2column"><!--<![endif]--><!--[if mso]> <div class='stb-two-col' style='text-align:center;' > <![endif]--><!--[if mso]> <table role='presentation' width='100%' cellpadding='0' cellspacing='0' style='border:0;'> <tr> <![endif]--><!--[if mso]> <td style='width:50%;padding:15px 15px 0px 15px;' valign='top'> <![endif]--><div class="stb-column" style="max-width:315px;width:100%!important;margin:0;vertical-align:top;border-collapse:collapse;box-sizing:border-box;font-size:16px;mso-table-lspace:0pt;mso-table-rspace:0pt;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;width:100%;display:inline-block;vertical-align:top;"><!--[if !mso]><!--><div style="padding:15px 15px 0px 15px;"><!--<![endif]--><!--[if mso]> <div > <![endif]--><div style="word-break:break-all;text-align:left;margin:0px;;line-height:1.7;word-break:break-word;font-size:16px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#000000;"><p data-pm-slice="0 0 []"><span style="font-size: 14px;">동광제약은 2014년부터 레바미피드 속방정을 판매하며 위염 치료제 시장에서 입지를 다져왔습니다.</span><span style="font-size: 14px;">오는 8월에는 복용 편의성을 높인 ‘동광레바미피드서방정’을 출시하며 급·만성 위염 치료 라인을 강화합니다. 해당 제품은 150mg 1일 2회 복용 제형으로, 내년 2월까지 우판권에 따라 독점 판매됩니다. </span><span style="font-size: 14px;">동광제약은 자사 소염진통제와의 병용 처방을 통해 매출 확대와 시장 선점을 기대하고 있습니다. [메디칼타임즈 -25.07.30]</span></p></div></div></div><!--[if mso]> </td> <![endif]--><!--[if mso]> <td style='width:50%;padding:15px 15px 0px 15px;' valign='top'> <![endif]--><div class="stb-column" style="max-width:315px;width:100%!important;margin:0;vertical-align:top;border-collapse:collapse;box-sizing:border-box;font-size:16px;mso-table-lspace:0pt;mso-table-rspace:0pt;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;width:100%;display:inline-block;vertical-align:top;"><!--[if !mso]><!--><div style="padding:15px 15px 0px 15px;"><!--<![endif]--><!--[if mso]> <div > <![endif]--><p style="text-align:center;font-size:0;box-sizing:border-box;"><img src="https://img2.stibee.com/440332_2928016_1754023715153742862.png?l23t9kpv" alt="" style="width:178px;display:inline;vertical-align:bottom;text-align:center;max-width:100% !important;height:auto;border:0;" width="178" class="stb-center"></p></div></div><!--[if mso]> </td> <![endif]--><!--[if mso]> </tr> </table> <![endif]--></div><table role="presentation" class="stb-one-col" style="width: 100%;background:#ffffff;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:15px 15px 15px 15px;border:0;width:100%;text-align:center;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#000000;mso-padding-alt:0px;border-radius:3px;border:1px solid ;mso-line-height-rule:exactly;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:3px;padding:17px 20px;text-align:center;" valign="top"><a href="https://www.brpinsight.com/distributor/44" style="font-size:14px;display:inline-block;color:#000000;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;" target="_blank"><b>BRPInsight 트렌드 - 동광제약 급‧만성 위염 라인업은? [클릭]</b></a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td class="stb-cta-box" width="100%" style="clear:both;;"><table border="0" cellpadding="0" cellspacing="0" style="width:100%;"><tbody><tr><td style="padding:15px 15px 15px 15px;border:0;width:100%;text-align:center;"><table class="stb-cell-wrap-cta" border="0" cellpadding="0" cellspacing="0" style="color:#ffffff;mso-padding-alt:0px;background:#000000;border-radius:500px;mso-line-height-rule:exactly;box-sizing:border-box;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;display:inline-table;"><tbody><tr><td style="font-size:0;background:none;border-radius:500px;padding:17px 20px;text-align:center;" valign="top"><a href="https://www.brpinsight.com/" style="font-size:14px;display:inline-block;color:#ffffff;text-decoration:none;outline:0px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;text-align:center;line-height:1;box-sizing:border-box;mso-line-height-rule:exactly;" target="_blank"><b>25,000여개 제품 트렌드 확인 하러가기 🏃♀️➡️</b></a></td></tr></tbody></table><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation"><tbody><tr></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;background:#000000;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;background:#000000;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="text-align:justify;font-size:0;box-sizing:border-box;padding:0px 0px 15px 0px;"><img src="https://img2.stibee.com/440332_2904285_1752761435069828722.png" alt="" style="width:100%;display:inline;vertical-align:bottom;text-align:justify;max-width:100% !important;height:auto;border:0;" width="630" class="stb-justify"></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table><table role="presentation" class="stb-one-col" style="width: 100%;border:0;" cellpadding="0" cellspacing="0"><tbody><tr><td style="text-align:justify;font-size:0;box-sizing:border-box;padding:15px 15px 15px 15px;"><a href="https://www.brpinsight.com/signup" target="_blank" style="text-decoration: none; color: #0000ff;"><img src="https://img2.stibee.com/440332_2907895_1753111661657417507.png?8xbf0xo9" alt="" style="width:100%;display:inline;vertical-align:bottom;text-align:justify;max-width:100% !important;height:auto;border:0;" width="600" class="stb-justify"></a></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td class="stb-text-box stb-permalink stb-footer" style="text-align:center;margin:0px;;line-height:1.7;word-break:break-word;font-size:12px;font-family:noto sans kr, noto sans cjk kr, noto sans cjk, Malgun Gothic, apple sd gothic neo, nanum gothic, malgun gothic, dotum, arial, helvetica, Meiryo, MS Gothic, sans-serif!important;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;color:#747579;border:0;"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="padding:15px 15px 15px 15px;text-align:center;"><div><span>BRPInsight</span><br><span>brpnews@brpinsight.com</span><br><span class="stb-fore-colored">(주)BRP커넥트 | 서울 강남구 역삼로 169 명우빌딩 | </span><br><a href="https://stibee.com/error/preview" class="stb-underline stb-marked" target="_blank" rel="noopener" style="color: #747579;">수신거부</a><span> </span><a href="https://stibee.com/error/preview" class="stb-underline stb-marked" target="_blank" rel="noopener" style="color: #747579;">Unsubscribe</a></div></td></tr></tbody></table></td></tr></tbody></table><table width="100%" cellpadding="0" cellspacing="0" style="border:0;"><tbody><tr><td style="height:15px;" colspan="3"></td></tr><tr><td style="width:15px;"></td><td style="height:15px;background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;"><!-- <div style='background: none;padding: 0px;border-top-width:1px;border-top-style:solid;border-top-color:#999999;margin:0 0;'></div> --></td><td style="width:15px;"></td></tr></tbody></table></div><!--[if mso]> </td> </tr> </table> <![endif]--></td></tr></tbody></table><div style="padding: 10pt 0cm 10pt 0cm;"><p class="MsoNormal" align="center" style="text-align: center;"><span lang="EN-US"></span></p></div></div></body></html>